RTOG 0229: A phase II trial of neoadjuvant therapy with concurrent chemotherapy and high-dose radiotherapy (XRT) followed by resection and consolidative therapy for LA-NSCLC.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7024-7024
◽
2010 ◽
Vol 78
(3)
◽
pp. S111
◽